These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma. Chen YT; Tu JJ; Kao J; Zhou XK; Mazumdar M Clin Cancer Res; 2005 Sep; 11(18):6558-66. PubMed ID: 16166433 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical Panel for Differentiating Renal Cell Carcinoma with Clear and Papillary Features. Alshenawy HA Pathol Oncol Res; 2015 Sep; 21(4):893-9. PubMed ID: 25712789 [TBL] [Abstract][Full Text] [Related]
5. Alpha-methylacyl-CoA racemase as a marker in the differential diagnosis of metanephric adenoma. Olgac S; Hutchinson B; Tickoo SK; Reuter VE Mod Pathol; 2006 Feb; 19(2):218-24. PubMed ID: 16424894 [TBL] [Abstract][Full Text] [Related]
6. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases. Pan CC; Chen PC; Ho DM Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648 [TBL] [Abstract][Full Text] [Related]
7. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma. Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis. Liu L; Qian J; Singh H; Meiers I; Zhou X; Bostwick DG Arch Pathol Lab Med; 2007 Aug; 131(8):1290-7. PubMed ID: 17683191 [TBL] [Abstract][Full Text] [Related]
9. Recent advances of immunohistochemistry for diagnosis of renal tumors. Kuroda N; Tanaka A; Ohe C; Nagashima Y Pathol Int; 2013 Aug; 63(8):381-90. PubMed ID: 23957913 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney: significant immunophenotypic overlap warrants diagnostic caution. Paner GP; Srigley JR; Radhakrishnan A; Cohen C; Skinnider BF; Tickoo SK; Young AN; Amin MB Am J Surg Pathol; 2006 Jan; 30(1):13-9. PubMed ID: 16330937 [TBL] [Abstract][Full Text] [Related]
11. Oncocytoma can be differentiated from its renal cell carcinoma mimics by a panel of markers: an automated tissue microarray study. Huang W; Kanehira K; Drew S; Pier T Appl Immunohistochem Mol Morphol; 2009 Jan; 17(1):12-7. PubMed ID: 18769342 [TBL] [Abstract][Full Text] [Related]
12. Claudin-7 immunohistochemistry in renal tumors: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling. Hornsby CD; Cohen C; Amin MB; Picken MM; Lawson D; Yin-Goen Q; Young AN Arch Pathol Lab Med; 2007 Oct; 131(10):1541-6. PubMed ID: 17922590 [TBL] [Abstract][Full Text] [Related]
13. Identification and validation of novel prognostic markers in Renal Cell Carcinoma. Rabjerg M Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890 [TBL] [Abstract][Full Text] [Related]
14. Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study. Bing Z; Lal P; Lu S; Ziober A; Tomaszewski JE Ann Diagn Pathol; 2013 Feb; 17(1):58-62. PubMed ID: 22898056 [TBL] [Abstract][Full Text] [Related]
15. Role Of Immunohistochemistry In Subtyping Renal Cell Carcinomas With Overlapping Morphological Features. Tariq N; Mamoon N; Haroon A; Ali Z; Ahmad IN J Ayub Med Coll Abbottabad; 2018; 30(3):325-332. PubMed ID: 30465359 [TBL] [Abstract][Full Text] [Related]
16. [Immunohistochemical profile of renal cell tumours]. Gutiérrez Olivares VM; González Torres LM; Hunter Cuartas G; Niebles De la Hoz MC Rev Esp Patol; 2019; 52(4):214-221. PubMed ID: 31530404 [TBL] [Abstract][Full Text] [Related]
17. Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma. Geramizadeh B; Ravanshad M; Rahsaz M Indian J Pathol Microbiol; 2008; 51(2):167-71. PubMed ID: 18603673 [TBL] [Abstract][Full Text] [Related]
18. Beta defensin-1, parvalbumin, and vimentin: a panel of diagnostic immunohistochemical markers for renal tumors derived from gene expression profiling studies using cDNA microarrays. Young AN; de Oliveira Salles PG; Lim SD; Cohen C; Petros JA; Marshall FF; Neish AS; Amin MB Am J Surg Pathol; 2003 Feb; 27(2):199-205. PubMed ID: 12548166 [TBL] [Abstract][Full Text] [Related]
19. [Study on clinicopathologic features and immunophenotype of 114 cases of renal cell carcinoma]. Zou H; Pang LJ; Hu WH; Li F; Li HA; Jiang JF; Liang WH; Sun ZZ; Wang C; Lang JY Zhonghua Bing Li Xue Za Zhi; 2008 Nov; 37(11):726-31. PubMed ID: 19094705 [TBL] [Abstract][Full Text] [Related]
20. Clear cell papillary renal cell carcinoma is the fourth most common histologic type of renal cell carcinoma in 290 consecutive nephrectomies for renal cell carcinoma. Zhou H; Zheng S; Truong LD; Ro JY; Ayala AG; Shen SS Hum Pathol; 2014 Jan; 45(1):59-64. PubMed ID: 24182559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]